CMS

New companies claimed stakes during the year, established firms solidified their plans and data, and Grail launched the first genomic multi-cancer early detection test.

To receive coverage, the patient must have a personal history of cancer where the type and staging are within the intended use of the test.

National Government Services' proposal to broaden coverage of large sequencing panels for solid tumor patients is positive but may need clarification to ensure appropriate patient care.